Why the study?
What is the epidemiology and outcome of infantile spasms treated with vigabatrin in Denmark?
What is the epidemiology and outcome of infantile spasms treated with vigabatrin in Denmark?
In a Danish cohort from 1996-2019, initial treatment with vigabatrin for infantile spasms resulted in seizure freedom in 44.7% of patients, though severe neurodevelopmental outcomes remained common.
Vigabatrin monotherapy yields limited seizure control amid severe neurodevelopment; leaves open optimal regimens and neuroprotection in infantile spasms.
In Denmark treatment algorithm is based on start of treatment with vigabatrin. A total of 44.7 % became seizure free by vigabatrin. Neurodevelopmental outcome was severe. A national incidence could be established.
No takes yet. Share an insight, caveat, or question.
Winther et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: